DOC
HEALTHPEAK PROPERTIES, INC.
Company overview
- Market capitalization
- $13.86B
- Employees
- 411
- Latest publication
- 2026-09-29
About HEALTHPEAK PROPERTIES, INC.
Healthpeak Properties, Inc. is a Standard & Poor's 500 company that owns, operates, and develops high-quality real estate focused on healthcare discovery and delivery in the United States. Our company was originally founded in 1985. We are organized as an umbrella partnership REIT. We hold substantially all our assets and conduct our operations through our operating subsidiary, Healthpeak OP, a consolidated subsidiary of which we are the managing member. We are a Maryland corporation and qualify as a self-administered REIT. We are headquartered in Denver, Colorado, with additional corporate offices in California, Tennessee, Wisconsin, and Massachusetts and property management offices in several locations throughout the U.S. We have a diversified portfolio of high-quality healthcare properties across three core asset classes of outpatient medical, lab, and continuing care retirement community real estate. Under the outpatient medical and lab segments, we own, operate, and develop outpatient medical buildings, hospitals, and lab buildings. Under the CCRC segment, our properties are operated through RIDEA structures. We have other non-reportable segments that are comprised primarily of: (i) an interest in an unconsolidated joint venture that owns 19 senior housing assets, (ii) loans receivable, and (iii) a preferred equity investment. These non-reportable segments have been presented on a combined basis herein. At September 30, 2025, our portfolio of investments, including properties in certain of our unconsolidated joint ventures, consisted of interests in 703 properties: (i) Outpatient medical " 530 properties; (ii) Lab " 139 properties; (iii) CCRC " 15 properties; and (iv) Other non-reportable " 19 properties. Healthpeak Properties, Inc. was incorporated in 1985 in Maryland, USA.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q4 20182018-12-31 · USD | Q4 20172017-12-31 · USD | Q1 20172017-03-31 · USD | Q4 20152015-12-31 · USD | Q2 20132013-06-30 · USD | Q1 20132013-03-31 · USD | Q1 20122012-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 771,579,000USD | 441,919,000USD | 443,259,000USD | 492,168,000USD | 668,036,000USD | 512,239,000USD | 511,186,000USD | 455,827,000USD |
| Cost Of Revenue | 716,486,000USD | 177,413,000USD | 198,669,000USD | 159,081,000USD | 172,487,000USD | 73,887,000USD | 72,686,000USD | 67,333,000USD |
| Gross Profit | 55,093,000USD | 264,506,000USD | 244,590,000USD | 333,087,000USD | 495,549,000USD | 438,352,000USD | 438,500,000USD | 388,494,000USD |
| Selling General Administrative | 22,517,000USD | 21,510,000USD | 21,485,000USD | 22,478,000USD | 21,870,000USD | 24,062,000USD | 20,656,000USD | 20,089,000USD |
| General And Administrative Expenses | 22,517,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 22,517,000USD | 152,269,000USD | 158,318,000USD | 159,032,000USD | 163,026,000USD | 133,272,000USD | 123,835,000USD | 105,369,000USD |
| Operating Income | 32,576,000USD | 112,237,000USD | 86,272,000USD | 174,055,000USD | 332,523,000USD | 305,080,000USD | 314,665,000USD | 283,125,000USD |
| Total Other Income Expense Net | 26,754,000USD | 719,211,000USD | -130,899,000USD | 283,960,000USD | -929,531,000USD | -89,579,000USD | -82,197,000USD | -89,641,000USD |
| Interest Income | 21,769,000USD | — | — | — | — | — | — | — |
| Interest Expense | 92,280,000USD | 54,717,000USD | 71,882,000USD | 86,718,000USD | 122,027,000USD | 108,452,000USD | 109,110,000USD | 103,752,000USD |
| Income Before Tax | 59,330,000USD | 831,448,000USD | -44,627,000USD | 458,015,000USD | -597,008,000USD | 215,501,000USD | 232,468,000USD | 193,484,000USD |
| Income Tax Expense | -1,402,000USD | -2,935,000USD | 13,297,000USD | -6,162,000USD | -2,391,000USD | 1,604,000USD | 916,000USD | -709,000USD |
| Equity Method Income Loss | 2,509,000USD | — | — | — | — | — | — | — |
| Net Income | 63,241,000USD | 831,548,000USD | -58,702,000USD | 461,145,000USD | -598,868,000USD | 213,401,000USD | 230,585,000USD | 193,380,000USD |
| Minority Interest | 10,423,000USD | 568,152,000USD | — | — | — | — | — | — |
| Net Income Applicable To Common Shares | 52,668,000USD | 830,157,000USD | — | — | — | — | — | — |
| Unclassified Operating Expenses | — | 130,759,000USD | 136,833,000USD | 136,554,000USD | 141,156,000USD | 109,210,000USD | 103,179,000USD | 85,280,000USD |
| Net Income From Continuing Ops | — | 834,383,000USD | — | — | — | — | — | — |
| Ebit | — | 888,317,000USD | 20,925,000USD | 541,464,000USD | -479,717,000USD | 308,368,000USD | 326,777,000USD | 283,561,000USD |
| Ebitda | — | 1,019,076,000USD | 157,758,000USD | 678,018,000USD | -338,561,000USD | 417,578,000USD | 429,956,000USD | 368,841,000USD |
| Depreciation And Amortization | — | 130,759,000USD | 136,833,000USD | 136,554,000USD | 141,156,000USD | 109,210,000USD | 103,179,000USD | 85,280,000USD |
| Reconciled Depreciation | — | 130,759,000USD | 136,833,000USD | 136,554,000USD | 140,841,000USD | 104,607,000USD | 104,639,000USD | 87,579,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20112011-12-31 · USD | FY 19981998-12-31 · USD | FY 19971997-12-31 · USD | FY 19961996-12-31 · USD | FY 19951995-12-31 · USD | FY 19941994-12-31 · USD | FY 19931993-12-31 · USD | FY 19921992-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,694,418,000USD | 161,549,000USD | 128,503,000USD | 120,393,000USD | 105,696,000USD | 98,996,000USD | 92,500,000USD | 83,700,000USD |
| Cost Of Revenue | 218,701,000USD | 5,053,000USD | — | — | — | — | — | — |
| Gross Profit | 1,475,717,000USD | 156,496,000USD | 128,503,000USD | 120,393,000USD | 105,696,000USD | 98,996,000USD | 92,500,000USD | 83,700,000USD |
| Selling General Administrative | 96,059,000USD | — | — | — | — | — | — | — |
| Unclassified Operating Expenses | 346,055,000USD | 41,089,000USD | — | — | — | — | -25,300,000USD | -24,900,000USD |
| Total Operating Expenses | 442,114,000USD | 41,089,000USD | 62,057,000USD | 56,376,000USD | 45,301,000USD | 45,434,000USD | -25,300,000USD | -24,900,000USD |
| Operating Income | 1,033,603,000USD | 115,407,000USD | 66,446,000USD | 64,017,000USD | 60,395,000USD | 53,562,000USD | 117,800,000USD | 108,600,000USD |
| Interest Expense | 415,455,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Income Before Tax | 537,431,000USD | — | — | — | — | — | — | — |
| Income Tax Expense | 1,301,000USD | 31,186,000USD | 4,879,000USD | 5,825,000USD | -17,354,000USD | 3,585,000USD | 73,700,000USD | 72,900,000USD |
| Net Income | 538,891,000USD | 87,167,000USD | 64,789,000USD | 60,641,000USD | 80,266,000USD | 49,977,000USD | 44,100,000USD | 35,700,000USD |
| Ebit | 906,136,000USD | 118,353,000USD | 69,668,000USD | 66,466,000USD | 62,912,000USD | 53,562,000USD | 117,800,000USD | 108,600,000USD |
| Ebitda | 1,252,191,000USD | 147,930,000USD | 92,335,000USD | 87,166,000USD | 79,603,000USD | 71,083,000USD | 135,700,000USD | 126,700,000USD |
| Depreciation And Amortization | 346,055,000USD | 29,577,000USD | 22,667,000USD | 20,700,000USD | 16,691,000USD | 17,521,000USD | 17,900,000USD | 18,100,000USD |
| Total Other Income Expense Net | -496,172,000USD | — | — | — | — | — | — | — |
| Other Operating Expenses | — | — | 62,057,000USD | 56,376,000USD | 45,301,000USD | 45,434,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 21,680,046,000USD | 21,616,225,000USD | 20,336,018,000USD | 19,582,401,000USD | 19,810,267,000USD | 19,815,729,000USD | 19,938,255,000USD | 19,969,766,000USD |
| Cash And Equivalents | 1,626,827,000USD | — | 467,457,000USD | 91,038,000USD | 89,436,000USD | 70,625,000USD | 119,818,000USD | 180,430,000USD |
| Total Liabilities | 12,181,606,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 7,844,750,000USD | 7,826,288,000USD | 7,500,094,000USD | 7,597,275,000USD | 7,928,100,000USD | 8,188,047,000USD | 8,401,276,000USD | 8,562,839,000USD |
| Total Equity Including Noncontrolling Interest | 9,498,440,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 395,124,000USD | 395,929,000USD | 412,198,000USD | 417,365,000USD | 426,631,000USD | 422,017,000USD | 424,173,000USD | 427,711,000USD |
| Goodwill | 68,529,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 717,494,000USD | 758,495,000USD | 654,516,000USD | 610,513,000USD | 677,101,000USD | 747,789,000USD | 817,254,000USD | 898,379,000USD |
| Common Stock | 689,465,000USD | 695,263,000USD | 695,037,000USD | 694,946,000USD | 694,916,000USD | 698,612,000USD | 699,485,000USD | 699,405,000USD |
| Accumulated Other Comprehensive Income | 10,534,000USD | -464,000USD | -9,937,000USD | -7,975,000USD | -5,019,000USD | 6,927,000USD | 28,818,000USD | -12,381,000USD |
| Total Liab | — | 12,556,212,000USD | 12,033,567,000USD | 11,317,097,000USD | 11,223,326,000USD | 10,972,320,000USD | 10,880,631,000USD | 10,747,763,000USD |
| Other Current Liab | — | -1,279,226,000USD | -718,509,000USD | 457,556,000USD | 482,064,000USD | -517,982,000USD | -490,766,000USD | 420,138,000USD |
| Capital Stock | — | 695,263,000USD | 695,037,000USD | 694,946,000USD | 694,916,000USD | 698,612,000USD | 699,485,000USD | 699,405,000USD |
| Retained Earnings | — | -5,971,501,000USD | -5,952,920,000USD | -5,854,766,000USD | -5,525,520,000USD | -5,345,120,000USD | -5,174,279,000USD | -4,968,819,000USD |
| Good Will | — | 68,529,000USD | 68,529,000USD | — | 51,000,000USD | — | 68,529,000USD | 65,163,000USD |
| Other Assets | — | 18,470,322,000USD | 18,016,050,000USD | 17,789,983,000USD | 17,900,570,000USD | 75,821,000USD | 72,327,000USD | -61,615,000USD |
| Cash | — | 1,170,992,000USD | 537,702,000USD | 91,038,000USD | 89,436,000USD | 70,625,000USD | 119,818,000USD | 180,430,000USD |
| Cash And Short Term Investments | — | 1,170,992,000USD | 537,702,000USD | 91,038,000USD | 89,436,000USD | 70,625,000USD | 119,818,000USD | 180,430,000USD |
| Total Current Assets | — | 1,802,640,000USD | 1,073,477,000USD | 981,672,000USD | 994,266,000USD | 913,879,000USD | 986,145,000USD | 984,614,000USD |
| Total Current Liabilities | — | 892,768,000USD | 985,307,000USD | 1,126,725,000USD | 1,514,822,000USD | 834,221,000USD | 875,342,000USD | 1,653,252,000USD |
| Current Deferred Revenue | — | 1,007,201,000USD | 985,307,000USD | 970,077,000USD | 965,800,000USD | 939,855,000USD | 940,136,000USD | 903,371,000USD |
| Net Debt | — | 9,541,869,000USD | 9,902,712,000USD | 9,341,825,000USD | 9,261,916,000USD | 9,112,617,000USD | 8,903,451,000USD | 8,711,224,000USD |
| Short Term Debt | — | 892,768,000USD | 0USD | 368,125,000USD | 775,000,000USD | 164,000,000USD | 150,000,000USD | 27,489,000USD |
| Short Long Term Debt | — | 1,751,409,000USD | 1,078,850,000USD | 368,125,000USD | 775,000,000USD | 164,000,000USD | 150,000,000USD | — |
| Short Long Term Debt Total | — | 10,712,861,000USD | 10,440,414,000USD | 9,432,863,000USD | 9,351,352,000USD | 9,183,242,000USD | 9,023,269,000USD | 8,891,654,000USD |
| Long Term Debt | — | 8,671,363,000USD | 8,769,044,000USD | 8,763,436,000USD | 9,041,253,000USD | 8,712,665,000USD | 8,566,049,000USD | 8,583,377,000USD |
| Long Term Investments | — | 530,354,000USD | 802,601,000USD | 796,171,000USD | 963,379,000USD | 951,978,000USD | 936,814,000USD | 931,844,000USD |
| Net Receivables | — | 631,648,000USD | 684,347,000USD | 754,347,000USD | 785,270,000USD | 1,116,433,000USD | 794,000,000USD | 742,569,000USD |
| Accounts Payable | — | 272,025,000USD | 718,509,000USD | 301,044,000USD | 257,758,000USD | 248,348,000USD | 275,972,000USD | 329,743,000USD |
| Property Plant Equipment Gross | — | 395,929,000USD | 412,198,000USD | 417,365,000USD | 426,631,000USD | 422,017,000USD | 424,173,000USD | 427,711,000USD |
| Common Stock Shares Outstanding | — | 695,168,000shares | 696,044,000shares | 696,380,000shares | 697,146,000shares | 699,118,000shares | 699,596,000shares | 700,146,000shares |
| Non Current Assets Total | — | 1,343,263,000USD | 1,246,491,000USD | 18,600,729,000USD | 18,816,001,000USD | 18,901,850,000USD | 18,952,110,000USD | 18,985,152,000USD |
| Non Current Liabilities Total | — | 11,663,444,000USD | 11,048,260,000USD | 10,190,372,000USD | 9,708,504,000USD | 10,138,099,000USD | 10,005,289,000USD | 9,094,511,000USD |
| Non Current Liabilities Other | — | 164,360,000USD | 173,697,000USD | 155,557,000USD | 166,352,000USD | 179,002,000USD | 191,884,000USD | 202,857,000USD |
| Non Currrent Assets Other | — | -17,367,158,000USD | -802,601,000USD | 16,776,680,000USD | 16,748,890,000USD | 16,763,191,000USD | 16,773,869,000USD | 16,727,218,000USD |
| Net Working Capital | — | -388,508,000USD | -506,589,000USD | -145,053,000USD | -520,556,000USD | 79,658,000USD | 110,803,000USD | -668,638,000USD |
| Unclassified Non Current Assets | — | -18,880,366,000USD | -18,707,403,000USD | -17,789,983,000USD | -17,951,570,000USD | — | — | — |
| Unclassified Current Liabilities | — | -3,030,635,000USD | -1,797,359,000USD | -1,338,202,000USD | -1,740,800,000USD | -681,982,000USD | -640,766,000USD | -27,489,000USD |
| Unclassified Non Current Liabilities | — | 2,827,721,000USD | 2,105,519,000USD | 1,271,379,000USD | 500,899,000USD | 1,246,432,000USD | 1,247,356,000USD | 308,277,000USD |
| Unclassified Equity | — | 12,407,727,000USD | 12,072,877,000USD | 12,070,124,000USD | 12,068,807,000USD | 12,129,016,000USD | 12,147,767,000USD | 12,145,229,000USD |
| Other Current Assets | — | — | -148,572,000USD | 136,287,000USD | 119,560,000USD | -273,179,000USD | 72,327,000USD | 61,615,000USD |
| Unclassified Current Assets | — | — | -148,572,000USD | — | — | -286,693,000USD | — | -61,615,000USD |
| Short Term Investments | — | — | — | — | — | 13,514,000USD | — | 61,615,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 20,336,018,000USD | 19,938,255,000USD | 15,698,850,000USD | 15,771,229,000USD | 15,257,519,000USD | 15,920,089,000USD | 4,346,581,000USD | 4,142,834,000USD |
| Intangible Assets | 654,516,000USD | 817,254,000USD | 314,156,000USD | 418,061,000USD | 519,760,000USD | 519,917,000USD | 390,450,000USD | 452,384,000USD |
| Other Current Assets | -148,572,000USD | 72,327,000USD | 169,374,000USD | 104,668,000USD | 90,644,000USD | 2,693,512,000USD | -107,013,000USD | 21,551,000USD |
| Total Liab | 12,033,567,000USD | 10,880,631,000USD | 8,773,980,000USD | 8,482,952,000USD | 8,111,415,000USD | 8,572,743,000USD | 1,837,697,000USD | 1,670,427,000USD |
| Total Stockholder Equity | 7,500,094,000USD | 8,401,276,000USD | 6,350,446,000USD | 6,654,701,000USD | 6,515,470,000USD | 6,733,723,000USD | 2,508,884,000USD | 2,472,407,000USD |
| Other Current Liab | -718,509,000USD | 427,856,000USD | 417,667,000USD | 510,959,000USD | 542,802,000USD | 132,893,000USD | -147,044,000USD | 99,060,000USD |
| Common Stock | 695,037,000USD | 699,485,000USD | 547,156,000USD | 546,642,000USD | 539,097,000USD | 538,405,000USD | 1,900,000USD | 1,824,000USD |
| Capital Stock | 695,037,000USD | 699,485,000USD | 547,156,000USD | 546,642,000USD | 539,097,000USD | 538,405,000USD | 505,222,000USD | 477,496,000USD |
| Retained Earnings | -5,952,920,000USD | -5,174,279,000USD | -1,061,293,000USD | -4,269,689,000USD | -4,120,774,000USD | -3,976,232,000USD | -529,194,000USD | -428,307,000USD |
| Good Will | 68,529,000USD | 68,529,000USD | 18,000,000USD | 18,000,000USD | 18,000,000USD | 18,000,000USD | — | — |
| Other Assets | 18,016,050,000USD | 187,419,000USD | -21,359,000USD | 13,962,309,000USD | 14,118,955,000USD | 665,106,000USD | 538,369,000USD | 591,088,000USD |
| Cash | 537,702,000USD | 119,818,000USD | 117,635,000USD | 72,032,000USD | 158,287,000USD | 44,226,000USD | 2,355,000USD | 19,161,000USD |
| Cash And Equivalents | 467,457,000USD | 119,818,000USD | 117,635,000USD | 72,032,000USD | — | — | — | — |
| Cash And Short Term Investments | 537,702,000USD | 119,818,000USD | 117,635,000USD | 72,032,000USD | 158,287,000USD | 44,226,000USD | 2,355,000USD | 19,161,000USD |
| Total Current Assets | 1,073,477,000USD | 986,145,000USD | 561,279,000USD | 604,968,000USD | 713,433,000USD | 2,975,382,000USD | 188,567,000USD | 83,701,000USD |
| Total Current Liabilities | 985,307,000USD | 875,342,000USD | 1,377,925,000USD | 1,772,161,000USD | 1,936,415,000USD | 1,305,944,000USD | 717,181,000USD | 581,377,000USD |
| Current Deferred Revenue | 985,307,000USD | — | -16,950,000USD | 844,076,000USD | 527,746,000USD | 774,316,000USD | 274,554,000USD | 21,043,000USD |
| Net Debt | 9,902,712,000USD | 8,903,451,000USD | 6,965,407,000USD | 6,634,096,000USD | 6,216,249,000USD | 6,433,648,000USD | 1,695,388,000USD | 1,513,692,000USD |
| Short Term Debt | 994,999,000USD | 171,514,000USD | 720,000,000USD | 995,606,000USD | 1,165,975,000USD | 129,590,000USD | 583,323,000USD | 457,388,000USD |
| Short Long Term Debt | 1,078,850,000USD | 150,000,000USD | 720,000,000USD | 995,606,000USD | 1,165,975,000USD | 129,590,000USD | 4,685,000USD | 3,561,000USD |
| Short Long Term Debt Total | 10,440,414,000USD | 9,023,269,000USD | 7,083,042,000USD | 6,706,128,000USD | 6,374,536,000USD | 6,477,874,000USD | 6,930,804,000USD | 6,021,735,000USD |
| Long Term Debt | 8,769,044,000USD | 8,566,049,000USD | 6,156,299,000USD | 5,502,007,000USD | 5,004,014,000USD | 6,297,979,000USD | 6,351,613,000USD | 5,567,908,000USD |
| Long Term Investments | 802,601,000USD | 936,814,000USD | 782,853,000USD | 706,677,000USD | 448,340,000USD | 447,577,000USD | 910,119,000USD | 1,253,906,000USD |
| Net Receivables | 684,347,000USD | 794,000,000USD | 274,270,000USD | 428,268,000USD | 464,502,000USD | 237,644,000USD | 186,212,000USD | 64,540,000USD |
| Accounts Payable | 718,509,000USD | 275,972,000USD | 240,258,000USD | 265,596,000USD | 227,638,000USD | 269,145,000USD | 6,348,000USD | 3,886,000USD |
| Property Plant Equipment Net | 412,198,000USD | 424,173,000USD | 240,155,000USD | 237,318,000USD | 233,942,000USD | 192,349,000USD | 127,933,000USD | 10,209,450,000USD |
| Property Plant Equipment Gross | 412,198,000USD | 424,173,000USD | 240,155,000USD | 237,318,000USD | 233,942,000USD | 192,349,000USD | 172,486,000USD | — |
| Accumulated Other Comprehensive Income | -9,937,000USD | 28,818,000USD | 19,371,000USD | 28,134,000USD | -3,147,000USD | -3,685,000USD | 4,321,000USD | 14,433,000USD |
| Common Stock Shares Outstanding | 696,044,000shares | 676,233,000shares | 547,275,000shares | 539,147,000shares | 539,241,000shares | 531,056,000shares | 489,335,000shares | 187,526,762shares |
| Non Current Assets Total | 1,246,491,000USD | 18,952,110,000USD | 15,137,571,000USD | 15,166,261,000USD | 14,544,086,000USD | 12,944,707,000USD | 4,158,014,000USD | 4,059,133,000USD |
| Non Current Liabilities Total | 11,048,260,000USD | 10,005,289,000USD | 7,396,055,000USD | 6,710,791,000USD | 6,175,000,000USD | 7,266,799,000USD | 1,120,516,000USD | 1,089,050,000USD |
| Non Current Liabilities Other | 173,697,000USD | 191,884,000USD | 127,380,000USD | 156,193,000USD | 177,232,000USD | 144,199,000USD | 74,991,000USD | 54,663,000USD |
| Non Currrent Assets Other | -802,601,000USD | 16,773,869,000USD | 13,800,407,000USD | 13,804,205,000USD | 13,342,044,000USD | 11,784,864,000USD | 134,942,000USD | -6,657,753,000USD |
| Net Working Capital | -506,589,000USD | 110,803,000USD | -816,646,000USD | -1,167,193,000USD | -1,222,982,000USD | 892,348,000USD | 63,845,000USD | -304,393,000USD |
| Unclassified Current Assets | -148,572,000USD | — | -634,026,000USD | — | — | — | -4,933,000USD | -21,551,000USD |
| Unclassified Non Current Assets | -18,707,403,000USD | -255,948,000USD | — | -13,980,309,000USD | -14,136,955,000USD | -683,106,000USD | 2,056,201,000USD | -8,447,695,000USD |
| Unclassified Current Liabilities | -2,792,358,000USD | -150,000,000USD | -720,000,000USD | -1,839,682,000USD | -1,693,721,000USD | -129,590,000USD | -151,729,000USD | — |
| Unclassified Non Current Liabilities | 2,105,519,000USD | 1,247,356,000USD | 1,112,376,000USD | -395,276,000USD | -441,089,000USD | -506,631,000USD | -5,772,681,000USD | -4,778,867,000USD |
| Unclassified Equity | 12,072,877,000USD | 12,147,767,000USD | 6,298,056,000USD | 9,802,972,000USD | 9,561,197,000USD | 9,636,830,000USD | 2,526,635,000USD | 2,406,961,000USD |
| Short Term Investments | — | — | 21,359,000USD | 2,045,000USD | 397,000USD | — | 4,933,000USD | — |
| Inventory | — | — | 612,667,000USD | -12,574,000USD | 1,964,000USD | -10,908,000USD | -4,932,999USD | -21,551,000USD |
| Other Liab | — | — | — | 1,447,867,000USD | 1,434,843,000USD | 1,331,252,000USD | 466,593,000USD | 245,346,000USD |
| Net Tangible Assets | — | — | — | 6,236,640,000USD | 5,995,710,000USD | 6,268,428,000USD | 5,824,854,000USD | 5,639,360,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 573,124,000USD |
| Stock Based Compensation | 9,308,000USD |
| Deferred Income Tax | -3,097,000USD |
| Other Non Cash Items | 13,313,000USD |
| Change To Liabilities | -29,850,000USD |
| Change In Working Capital | -29,850,000USD |
| Operating Cash Flow | 621,981,000USD |
| Investing Cash Flow | -505,976,000USD |
| Net Common Stock Issuance | -101,561,000USD |
| Common Dividends Paid | -422,250,000USD |
| Other Financing Activities | 1,428,388,000USD |
| Unclassified Financing Cash Flow | 160,401,000USD |
| Financing Cash Flow | 1,064,978,000USD |
| Change In Cash | 1,180,983,000USD |
| End Cash Flow | 1,718,685,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 199,656,000USD | 121,792,000USD | -109,848,000USD | 39,019,000USD | 50,064,000USD | 10,672,000USD | 92,738,000USD | 152,716,000USD |
| Depreciation | 289,734,000USD | 225,339,000USD | 262,317,000USD | 265,916,000USD | 268,546,000USD | 274,469,000USD | 280,019,000USD | 283,498,000USD |
| Stock Based Compensation | 4,502,000USD | 4,000,000USD | 4,045,000USD | 1,738,000USD | 4,627,000USD | 3,608,000USD | 3,755,000USD | 4,814,000USD |
| Other Non Cash Items | -228,090,000USD | -70,141,000USD | 129,221,000USD | -26,017,000USD | -28,249,000USD | 17,127,000USD | -87,730,000USD | -152,580,000USD |
| Change To Account Receivables | 890,000USD | -26,023,000USD | -21,127,000USD | 23,671,000USD | 7,212,000USD | -42,931,000USD | -17,263,000USD | 21,505,000USD |
| Change In Working Capital | -3,835,000USD | 9,118,000USD | 31,425,000USD | 81,707,000USD | -16,505,000USD | -9,496,000USD | 29,330,000USD | 26,692,000USD |
| Total Cash From Operating Activities | 260,881,000USD | 294,084,000USD | 314,961,000USD | 363,485,000USD | 279,429,000USD | 283,531,000USD | 318,202,000USD | 316,200,000USD |
| Capital Expenditures | -23,956,000USD | -57,826,000USD | -27,261,000USD | -25,728,000USD | -203,573,000USD | -604,281,000USD | -23,509,000USD | -35,718,000USD |
| Free Cash Flow | 236,925,000USD | 294,084,000USD | 287,700,000USD | 363,485,000USD | 279,429,000USD | 283,531,000USD | 318,202,000USD | 316,200,000USD |
| Investments | 162,801,000USD | — | -188,080,000USD | -210,259,000USD | -230,714,000USD | -233,774,000USD | 30,229,000USD | 187,527,000USD |
| Total Cashflows From Investing Activities | -638,607,000USD | -405,620,000USD | -188,080,000USD | -210,259,000USD | -230,714,000USD | -233,774,000USD | 30,229,000USD | 187,527,000USD |
| Net Borrowings | 570,328,000USD | 709,785,000USD | 84,974,000USD | 158,288,000USD | 155,631,000USD | 126,258,000USD | -26,075,000USD | — |
| Total Cash From Financing Activities | 1,105,933,000USD | 489,506,000USD | -130,428,000USD | -128,553,000USD | -94,414,000USD | -107,497,000USD | -265,681,000USD | -501,590,000USD |
| Dividends Paid | -211,994,000USD | -211,861,000USD | -211,874,000USD | -211,881,000USD | -213,479,000USD | -209,819,000USD | -209,821,000USD | -210,943,000USD |
| Sale Purchase Of Stock | -1,374,000USD | -87,000USD | -17,000USD | -72,082,000USD | -24,959,000USD | -326,000USD | -20,135,000USD | -68,234,000USD |
| Issuance Of Capital Stock | 901,423,000USD | 842,000USD | 133,000USD | 107,000USD | 64,000USD | 76,000USD | 67,000USD | 80,000USD |
| Change In Cash | 728,207,000USD | 377,970,000USD | -3,547,000USD | 24,673,000USD | -45,699,000USD | -57,740,000USD | 82,750,000USD | 2,137,000USD |
| Begin Period Cash Flow | 537,702,000USD | 159,732,000USD | 163,279,000USD | 138,606,000USD | 184,305,000USD | 242,045,000USD | 159,295,000USD | 157,158,000USD |
| End Period Cash Flow | 1,265,909,000USD | 537,702,000USD | 159,732,000USD | 163,279,000USD | 138,606,000USD | 184,305,000USD | 242,045,000USD | 159,295,000USD |
| Other Cashflows From Investing Activities | -23,654,000USD | -395,176,000USD | -165,658,000USD | -188,786,000USD | -198,280,000USD | -226,622,000USD | 47,256,000USD | 198,329,000USD |
| Other Cashflows From Financing Activities | 759,197,000USD | -9,173,000USD | -3,644,000USD | -2,985,000USD | -11,671,000USD | -23,686,000USD | -9,717,000USD | -63,311,000USD |
| Unclassified Investing Cash Flow | -753,798,000USD | 47,382,000USD | 192,919,000USD | 214,514,000USD | 401,853,000USD | 830,903,000USD | -23,747,000USD | -162,611,000USD |
| Unclassified Operating Cash Flow | — | 3,976,000USD | — | — | — | -12,849,000USD | — | — |
| Unclassified Financing Cash Flow | — | — | — | — | — | — | — | -159,102,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 101,027,000USD | 267,303,000USD | 334,757,000USD | 516,424,000USD | 525,930,000USD | 428,253,000USD | 60,061,000USD | 1,073,474,000USD |
| Depreciation | 1,022,118,000USD | 1,057,205,000USD | 749,901,000USD | 710,569,000USD | 684,286,000USD | 697,143,000USD | 659,989,000USD | 549,499,000USD |
| Stock Based Compensation | 14,410,000USD | 31,766,000USD | 14,480,000USD | 26,456,000USD | 18,202,000USD | 17,368,000USD | 18,162,000USD | 16,563,000USD |
| Other Non Cash Items | 4,814,000USD | -328,859,000USD | -211,236,000USD | -466,047,000USD | -453,772,000USD | -478,536,000USD | 104,226,000USD | -818,613,000USD |
| Change To Account Receivables | -16,267,000USD | -40,860,000USD | -21,566,000USD | -17,433,000USD | 18,626,000USD | 15,281,000USD | -49,771,000USD | 5,686,000USD |
| Change In Working Capital | 105,745,000USD | 44,775,000USD | 82,945,000USD | 118,860,000USD | 26,394,000USD | 108,776,000USD | 21,888,000USD | 46,311,000USD |
| Total Cash From Operating Activities | 1,251,959,000USD | 1,070,497,000USD | 956,242,000USD | 900,261,000USD | 795,248,000USD | 758,431,000USD | 846,073,000USD | 848,709,000USD |
| Capital Expenditures | -133,951,000USD | -115,784,000USD | -113,596,000USD | -108,510,000USD | -111,480,000USD | -639,287,000USD | -2,000,734,000USD | -34,638,000USD |
| Free Cash Flow | 1,251,959,000USD | 1,070,497,000USD | 956,242,000USD | 791,751,000USD | 795,248,000USD | 119,144,000USD | 846,073,000USD | 848,709,000USD |
| Total Cashflows From Investing Activities | -1,034,673,000USD | -113,799,000USD | -576,754,000USD | -876,343,000USD | 531,032,000USD | -1,007,700,000USD | -1,448,778,000USD | 1,829,279,000USD |
| Net Borrowings | 1,108,678,000USD | 153,220,000USD | 378,083,000USD | 324,583,000USD | -301,014,000USD | 62,997,000USD | 653,668,000USD | -2,313,107,000USD |
| Total Cash From Financing Activities | 136,111,000USD | -941,416,000USD | -337,299,000USD | -116,532,000USD | -1,288,517,000USD | 246,450,000USD | 647,271,000USD | -2,620,536,000USD |
| Dividends Paid | -849,095,000USD | -794,783,000USD | -657,021,000USD | -648,047,000USD | -650,082,000USD | -787,072,000USD | -720,123,000USD | -696,913,000USD |
| Sale Purchase Of Stock | -97,145,000USD | -190,690,000USD | -6,524,000USD | -67,838,000USD | -12,841,000USD | -10,529,000USD | -5,043,000USD | -3,432,000USD |
| Issuance Of Capital Stock | 1,146,000USD | 317,000USD | 278,000USD | 308,100,000USD | 5,036,000USD | 1,068,877,000USD | 795,586,000USD | 217,656,000USD |
| Change In Cash | 353,397,000USD | 15,282,000USD | 42,189,000USD | -92,614,000USD | 37,763,000USD | -73,225,000USD | 44,811,000USD | 57,643,000USD |
| Begin Period Cash Flow | 184,305,000USD | 169,023,000USD | 126,834,000USD | 219,448,000USD | 181,685,000USD | 184,657,000USD | 139,846,000USD | 82,203,000USD |
| End Period Cash Flow | 537,702,000USD | 184,305,000USD | 169,023,000USD | 126,834,000USD | 219,448,000USD | 111,432,000USD | 184,657,000USD | 61,145,000USD |
| Other Cashflows From Investing Activities | -947,900,000USD | 1,356,000USD | -488,363,000USD | 1,450,000USD | 1,450,000USD | 1,802,000USD | 9,359,000USD | 963,752,000USD |
| Other Cashflows From Financing Activities | -27,473,000USD | -109,480,000USD | -52,115,000USD | 16,348,823,000USD | 17,580,371,000USD | 543,517,000USD | 2,230,993,000USD | -757,408,000USD |
| Unclassified Investing Cash Flow | 47,178,000USD | 114,428,000USD | 684,521,000USD | 107,060,000USD | 628,682,000USD | 637,485,000USD | 1,991,375,000USD | -929,114,000USD |
| Investments | — | -113,799,000USD | -659,316,000USD | -876,343,000USD | 12,380,000USD | -1,007,700,000USD | -1,448,778,000USD | 1,829,279,000USD |
| Change To Inventory | — | — | 104,511,000USD | 17,433,000USD | -18,626,000USD | -15,281,000USD | 49,771,000USD | 16,738,000USD |
| Unclassified Operating Cash Flow | — | — | -14,605,000USD | — | — | -14,573,000USD | -18,253,000USD | -18,525,000USD |
| Change To Liabilities | — | — | — | 136,293,000USD | 7,768,000USD | 93,495,000USD | 71,659,000USD | 40,625,000USD |
| Unclassified Financing Cash Flow | — | — | — | -16,074,053,000USD | -17,904,951,000USD | 437,537,000USD | -1,512,224,000USD | 1,150,324,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Segment | Lab | 216,112,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Outpatient Medical | 310,670,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Senior Housing | 216,456,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Segment | Lab | 212,812,000 | USD | 0001628280-26-031287 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Outpatient Medical | 318,217,000 | USD | 0001628280-26-031287 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Senior Housing | 200,345,000 | USD | 0001628280-26-031287 |
| FY 2025Yearly · 2025-12-31 | Segment | Lab | 860,020,000 | USD | 0001628280-26-005044 |
| FY 2025Yearly · 2025-12-31 | Segment | Outpatient Medical | 1,273,505,000 | USD | 0001628280-26-005044 |
| FY 2025Yearly · 2025-12-31 | Segment | Senior Housing | 603,989,000 | USD | 0001628280-26-005044 |
| Q3 2025Quarterly · 2025-09-30 | Segment | CCRC | 150,458,000 | USD | 0001628280-25-046273 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Lab Buildings | 213,325,000 | USD | 0001628280-25-046273 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Outpatient Medical Buildings | 326,561,000 | USD | 0001628280-25-046273 |
| Q2 2025Quarterly · 2025-06-30 | Segment | CCRC | 148,855,000 | USD | 0001628280-25-036063 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Lab Buildings | 209,205,000 | USD | 0001628280-25-036063 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Outpatient Medical Buildings | 320,482,000 | USD | 0001628280-25-036063 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Lab | 217,593,000 | USD | 0001628280-26-031287 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Outpatient Medical | 314,457,000 | USD | 0001628280-26-031287 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Senior Housing | 148,927,000 | USD | 0001628280-26-031287 |
| FY 2024Yearly · 2024-12-31 | Segment | Lab | 881,452,000 | USD | 0001628280-26-005044 |
| FY 2024Yearly · 2024-12-31 | Segment | Outpatient Medical | 1,184,660,000 | USD | 0001628280-26-005044 |
| FY 2024Yearly · 2024-12-31 | Segment | Senior Housing | 568,475,000 | USD | 0001628280-26-005044 |
| Q3 2024Quarterly · 2024-09-30 | Segment | CCRC | 142,845,000 | USD | 0001628280-25-046273 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Lab Buildings | 225,592,000 | USD | 0001628280-25-046273 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Outpatient Medical Buildings | 317,659,000 | USD | 0001628280-25-046273 |
| Q2 2024Quarterly · 2024-06-30 | Segment | CCRC | 140,891,000 | USD | 0001628280-25-036063 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Lab Buildings | 214,266,000 | USD | 0001628280-25-036063 |
| Q2 2024Quarterly · 2024-06-30 | Segment | Outpatient Medical Buildings | 332,515,000 | USD | 0001628280-25-036063 |
| Q1 2024Quarterly · 2024-03-31 | Segment | CCRC | 138,776,000 | USD | 0001628280-24-018706 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Lab | 223,761,000 | USD | 0001628280-24-018706 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Other Non Reporting | 5,751,000 | USD | 0001628280-24-018706 |
| Q1 2024Quarterly · 2024-03-31 | Segment | Outpatient Medical Buildings | 238,272,000 | USD | 0001628280-24-018706 |
| FY 2023Yearly · 2023-12-31 | Segment | Lab | 878,326,000 | USD | 0001628280-26-005044 |
| FY 2023Yearly · 2023-12-31 | Segment | Outpatient Medical | 732,279,000 | USD | 0001628280-26-005044 |
| FY 2023Yearly · 2023-12-31 | Segment | Senior Housing | 527,417,000 | USD | 0001628280-26-005044 |
| FY 2022Yearly · 2022-12-31 | Segment | CCRC | 494,935,000 | USD | 0001628280-25-003748 |
| FY 2022Yearly · 2022-12-31 | Segment | Lab | 817,573,000 | USD | 0001628280-25-003748 |
| FY 2022Yearly · 2022-12-31 | Segment | Outpatient Medical | 725,370,000 | USD | 0001628280-25-003748 |
| FY 2021Yearly · 2021-12-31 | Segment | CCRC | 471,325,000 | USD | 0001628280-24-004094 |
| FY 2021Yearly · 2021-12-31 | Segment | Lab | 715,844,000 | USD | 0001628280-24-004094 |
| FY 2021Yearly · 2021-12-31 | Segment | Other Non Reporting | 37,773,000 | USD | 0001628280-24-004094 |
| FY 2021Yearly · 2021-12-31 | Segment | Outpatient Medical | 671,242,000 | USD | 0001628280-24-004094 |
| FY 2020Yearly · 2020-12-31 | Segment | CCRC | 436,494,000 | USD | 0001628280-23-002794 |
| FY 2020Yearly · 2020-12-31 | Segment | Life Science | 569,296,000 | USD | 0001628280-23-002794 |
| FY 2020Yearly · 2020-12-31 | Segment | Medical Office | 622,398,000 | USD | 0001628280-23-002794 |
| FY 2020Yearly · 2020-12-31 | Segment | Other Non Reporting | 16,687,000 | USD | 0001628280-23-002794 |
| FY 2018Yearly · 2018-12-31 | Segment | CCRC | 0 | USD | 0001628280-21-001804 |
| FY 2018Yearly · 2018-12-31 | Segment | Lifescience | 395,064,000 | USD | 0001628280-21-001804 |
| FY 2018Yearly · 2018-12-31 | Segment | Medical Office | 596,399,000 | USD | 0001628280-21-001804 |
| FY 2018Yearly · 2018-12-31 | Segment | Other | 199,857,000 | USD | 0001628280-21-001804 |
| FY 2017Yearly · 2017-12-31 | Segment | All Other Segments | 138,157,000 | USD | 0001628280-20-001456 |
| FY 2017Yearly · 2017-12-31 | Segment | Lifescience | 358,816,000 | USD | 0001628280-20-001456 |
| FY 2017Yearly · 2017-12-31 | Segment | Medical Office | 512,385,000 | USD | 0001628280-20-001456 |
| FY 2017Yearly · 2017-12-31 | Segment | Senior Housing Operating Portfolio | 525,473,000 | USD | 0001628280-20-001456 |
| FY 2017Yearly · 2017-12-31 | Segment | Senior Housing Triple Net | 313,547,000 | USD | 0001628280-20-001456 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.